DISCOVERY LIFE SCIENCES Executive and Leadership Team

Gregory Herrema, the Chief Executive Officer at DISCOVERY LIFE SCIENCES, directs the overarching corporate strategy and operational vision. Herrema guides the company's global market leadership in biospecimen analysis, procurement, distribution, and scientific services, essential for the pharmaceutical, biotechnology, and diagnostics sectors. This leadership role involves setting strategic objectives to enhance HudsonAlpha Discovery's sequencing and bioinformatics capabilities, ensuring alignment with cutting-edge genomic research technologies. Gregory Herrema drives the consultative approach that empowers customers to overcome research obstacles and achieve accelerated end results. The focus remains on fostering innovation and scientific advancement across all company operations, solidifying DISCOVERY LIFE SCIENCES' position as a premier partner in discovery, translational, and clinical research.

Jason Scherer, the Chief Operating Officer at DISCOVERY LIFE SCIENCES, oversees the execution of daily operations and ensures the efficient delivery of biospecimen analysis, procurement, and distribution services. Scherer manages the integration of HudsonAlpha Discovery's advanced sequencing and bioinformatics platforms, optimizing workflows for discovery, translational, and clinical research support. This operational leadership is critical for maintaining DISCOVERY LIFE SCIENCES' global market position and upholding the company's commitment to scientific excellence. Jason Scherer drives the consultative engagement model, ensuring seamless collaboration with pharmaceutical, biotechnology, and diagnostics clients. The COO's responsibilities include enhancing operational scalability and implementing best practices across all service areas, directly contributing to faster research outcomes and client success.

McLean Collins, the President, Biospecimens Products & Services at DISCOVERY LIFE SCIENCES, leads the strategic direction and operational execution for the company's core biospecimen offerings. Collins drives the expansion and refinement of biospecimen analysis, procurement, and distribution services, catering to the specific needs of the pharmaceutical, biotechnology, and diagnostics industries. This leadership role ensures the seamless integration of HudsonAlpha Discovery's sequencing and bioinformatics expertise with biospecimen sourcing. McLean Collins fosters a client-centric model, emphasizing a consultative approach to overcome research obstacles and accelerate end results. The focus remains on delivering high-quality biospecimen products and services that underpin critical discovery, translational, and clinical research initiatives globally.

Todd Poley, the Chief Marketing Officer at DISCOVERY LIFE SCIENCES, architects and executes the global marketing strategy, driving brand awareness and market penetration for biospecimen analysis, procurement, and scientific services. Poley leads initiatives to communicate the value of HudsonAlpha Discovery's sequencing and bioinformatics division, highlighting its role in supporting cutting-edge genomic research. This marketing leadership ensures DISCOVERY LIFE SCIENCES effectively reaches and engages pharmaceutical, biotechnology, and diagnostics industry partners. Todd Poley oversees the development of compelling narratives that showcase the company's innovative, consultative approach to scientific challenges. The CMO's focus includes expanding market reach and solidifying the company's reputation as a global leader in supporting discovery, translational, and clinical research.

Tamara Bowles, the Chief Human Resources Officer at DISCOVERY LIFE SCIENCES, directs all human capital strategies, fostering a culture of scientific innovation and operational excellence. Bowles oversees talent acquisition, development, and retention programs, ensuring DISCOVERY LIFE SCIENCES attracts and retains top scientific and operational talent crucial for biospecimen analysis, procurement, and distribution services. This HR leadership is vital for supporting HudsonAlpha Discovery's advanced sequencing and bioinformatics capabilities. Tamara Bowles champions employee engagement initiatives that align with the company's consultative approach, empowering teams to effectively support pharmaceutical, biotechnology, and diagnostics clients. The CHRO's role is instrumental in building a high-performing workforce dedicated to advancing discovery, translational, and clinical research.